Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
CHART Trader
Monthly Subscription
for only
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN Company Description
Revance Therapeutics, Inc. (MM) RVNC NASDAQ Common Stock US7613301099
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0.45 +1.76% 25.95 26.8 25.8 26.1 25.5 20:00:00
more quote information »

Recent News

Date Time Source Heading
11/03/201716:31EDGARQuarterly Report (10-q)
11/02/201716:22EDGARCurrent Report Filing (8-k)
11/02/201716:05BWRevance Releases Third Quarter 2017 Results
10/18/201716:05BWRevance Therapeutics to Release Third Quarter 2017 Financial..
10/18/201708:00BWRevance Completes Patient Enrollment in Phase 2 Program for..
9/19/201716:05BWRevance to Participate in the Cantor Fitzgerald 2017 Global..
9/06/201716:33EDGARCurrent Report Filing (8-k)
9/06/201707:30BWRevance Appoints Mark Foley to its Board of Directors
8/30/201716:05BWRevance to Participate in the 2017 Wells Fargo Securities..
8/25/201719:42EDGARStatement of Changes in Beneficial Ownership (4)
8/04/201717:10EDGARQuarterly Report (10-q)
8/03/201716:14EDGARCurrent Report Filing (8-k)
8/03/201716:05BWRevance Releases Second Quarter 2017 Results
8/02/201717:06EDGARCurrent Report Filing (8-k)
8/01/201716:05BWRevance Therapeutics Expands Leadership Team, Appointing..
7/24/201716:05BWRevance Therapeutics to Release Second Quarter 2017..
6/15/201708:00BWPositive BELMONT Phase 2 Trial Results Published in..
6/06/201708:04EDGARCurrent Report Filing (8-k)
6/05/201716:10EDGARCurrent Report Filing (8-k)
6/05/201716:05BWRevance Reports Additional Positive Week 24 Efficacy Results..
6/01/201716:30BWRevance to Participate in Upcoming Investor Conferences
5/24/201714:47EDGARConfidential Treatment Order (ct Order)
5/23/201711:04EDGARConfidential Treatment Order (ct Order)
5/22/201709:07EDGARConfidential Treatment Order (ct Order)
5/18/201716:24EDGARCurrent Report Filing (8-k)
5/18/201716:05BWRevance Announces Positive Top-Line 24-Week Duration of..
5/12/201719:51EDGARStatement of Changes in Beneficial Ownership (4)
5/12/201719:50EDGARStatement of Changes in Beneficial Ownership (4)
5/12/201719:49EDGARStatement of Changes in Beneficial Ownership (4)
5/12/201719:48EDGARStatement of Changes in Beneficial Ownership (4)
5/12/201719:46EDGARStatement of Changes in Beneficial Ownership (4)
5/12/201719:45EDGARStatement of Changes in Beneficial Ownership (4)
5/12/201716:48EDGARCurrent Report Filing (8-k)
5/09/201717:30EDGARCurrent Report Filing (8-k)
5/09/201717:14EDGARQuarterly Report (10-q)
5/09/201716:13EDGARCurrent Report Filing (8-k)
5/09/201716:05BWRevance Releases First Quarter 2017 Results
5/01/201707:30BWRevance Provides Update on Phase 2 Program for RT002..
4/25/201716:05BWRevance Therapeutics to Release First Quarter 2017 Financial..
3/24/201717:00EDGARProxy Statement (definitive) (def 14a)
3/17/201719:25EDGARStatement of Changes in Beneficial Ownership (4)
3/17/201719:24EDGARStatement of Changes in Beneficial Ownership (4)
3/15/201706:08EDGARCurrent Report Filing (8-k)
3/07/201708:10BWRevance Completes Enrollment in Phase 3 Pivotal Trials of..
3/03/201708:00BWRevance Announces BELMONT Phase 2 Clinical Data to Be..
2/28/201718:37EDGARSecurities Registration: Employee Benefit Plan (s-8)
2/28/201718:37EDGARAnnual Report (10-k)
2/27/201716:15EDGARCurrent Report Filing (8-k)
2/27/201716:05BWRevance Releases Fourth Quarter and Full Year 2016 Results
2/22/201716:05BWRevance to Participate in Upcoming Investor Conferences
See more news about this stock »
Your Recent History
Gulf Keyst..
FTSE 100
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20171118 08:14:58